Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in patients with coronary artery disease independent of obesity

Angiology

Volumn 49, Issue 8, 1998, Pages 607-612

  Psyrogiannis, Agathoklis J ^a   Alexopoulos, Dimitris K ^a   Kyriazopoulou, Venetsana E ^a   Vagenakis, Apostolos G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ANGIOGRAPHY; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031828158     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900803     Document Type: Article

References (17)

1. Reaven GM: Role of Insulin Resistance in Human Disease Diabetes, 1988, pp 1595-1607.
2. De Fronzo RA, Ferrannini F: Insulin resistance: A multifaceted syndrome, responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991.
3. Stoler MW: Atherosclerosis in diabetes: The role of hyperinsulinemia. Metabolism 37:1-9, 1988.
4. WHO Expert Committee on Diabetes Mellitus. Second Report, Technical Report Series 646, Geneva: WHO, 1980.
5. Miller GJ, Miller NF: Plasma high-density lipoprotein concentration and development of ischemic heart disease. Lancet A:16-19, 1975.
6. Baydade JD, Bierman EL, Porte D Jr: The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 46:1549-1557, 1967.
7. Bjorntrop P: "Portal" adipose tissue or a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10:493-496, 1990.
8. Koivisto VA, Yki-Jarrinen H, Hartling SG, et al: The effect of exogenous hyperinsulinemia on proinsulin secretion in normal man, obese subjects, and patients with insulinoma. J Clin Endocrinol Metab 63:1117-1120, 1986.
9. Saad MF, Kahn SF, Nelson RG, et al: Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70:1247-1253, 1990.
10. De Fronzo RA, Soman V, Sherwin RS, et al: Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62: 204-207, 1978.
11. Olefsky JM, Reaven GM, Farduhar J: Effects of weight reduction on obesity: Studies of carbohydrate and lipid metabolism. J Clin Invest 53:64-68, 1974.
12. Ajorala K, Savolainen F, Kankola S, et al: Plasma insulin as coronary heart disease risk factor: Relationship to other risk factors and predictive value during 9 1/2-year follow-up on the Helsinki Policemen Study Population. Acta Med Scand 705(suppl):38-52, 1985.
13. Welborn TW, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Burselton with reference to glucose and insulin concentration. Diabetes Care 2:154-160, 1979.
14. Fontbonne A, Charles MA, Thibult N, et al: Hyperinsulinemia as a predictor of coronary heart disease mortality in a healthy population: The Paris Prospective Study. 15-year follow-up. Diabetologia 34:356-361, 1991.
15. Barret-Conor E, Wingard DL, Criqui MH, et al: Is borderline fasting hyperglycemia a risk factor for cardiovascular death? J Chron Dis 37:773-779, 1984.
16. Vaccavo O, Ruth KJ, Stamler F: Relationship of post-load plasma glucose to mortality with 19-year follow-up. Diabetes Care 13:1328-1334, 1992.
17. Garrow J: Importance of obesity. Br Med J 303:704-706, 1991.